Suppr超能文献

用拉沙洛西减少3-甲基吲哚的产生并预防急性牛肺水肿和肺气肿。

Reduction of 3-methylindole production and prevention of acute bovine pulmonary edema and emphysema with lasalocid.

作者信息

Nocerini M R, Honeyfield D C, Carlson J R, Breeze R G

出版信息

J Anim Sci. 1985 Jan;60(1):232-8. doi: 10.2527/jas1985.601232x.

Abstract

A study was conducted to determine the dose of lasalocid that would effectively reduce ruminal conversion of tryptophan (TRP) to 3-methylindole (3MI) and prevent the development of acute bovine pulmonary edema and emphysema (ABPE). After adaptation to a maintenance diet for 3 wk, 20 mature beef cows were randomly divided into four groups of five cows each and fed 0, 200, 400 or 600 mg lasalocid X head-1 X d-1 in .5 kg ground barley for the 12-d experimental period. In vitro conversion of TRP to 3MI and indole by ruminal fluid and volatile fatty acid (VFA) concentrations were determined on d 0, 2, 4, 6 and 12. On d 6, an oral dose of .35 g TRP/kg body weight was given to induce ABPE, and ruminal production of 3MI and indole was determined at intervals thereafter. Formation of 3MI was sharply reduced (P less than .01) both in vitro and in vivo by lasalocid treatment at 200 mg X head-1 X d-1. Further suppression of 3MI production occurred as the lasalocid dose was increased (P less than .05). Linear (P less than .0001) and quadratic (P less than .002) components were determined for the relationship between lasalocid dose and 3MI production. Indole formation was variable, but tended to increase (P less than .05) with increasing lasalocid dose. Cows that received no lasalocid developed moderate to severe clinical signs of ABPE and three cows died of acute lung disease. Lasalocid treatment at all levels prevented ABPE. Lasalocid decreased ruminal acetate and butyrate, and increased propionate concentration (P less than .01).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

进行了一项研究,以确定能有效减少瘤胃中色氨酸(TRP)向3-甲基吲哚(3MI)转化并预防急性牛肺水肿和肺气肿(ABPE)发生的拉沙洛西剂量。在适应维持性日粮3周后,将20头成年肉牛随机分为四组,每组5头,在为期12天的试验期内,每头牛每天在0.5千克碎大麦中分别饲喂0、200、400或600毫克拉沙洛西。在第0、2、4、6和12天测定瘤胃液中TRP向3MI和吲哚的体外转化率以及挥发性脂肪酸(VFA)浓度。在第6天,口服剂量为0.35克TRP/千克体重以诱发ABPE,此后定期测定瘤胃中3MI和吲哚的生成量。200毫克/头/天的拉沙洛西处理在体外和体内均使3MI的生成量大幅减少(P<0.01)。随着拉沙洛西剂量增加,3MI生成量进一步受到抑制(P<0.05)。确定了拉沙洛西剂量与3MI生成量之间关系的线性(P<0.0001)和二次(P<0.002)成分。吲哚生成量变化不定,但随拉沙洛西剂量增加有增加趋势(P<0.05)。未接受拉沙洛西的母牛出现了中度至重度ABPE临床症状,3头母牛死于急性肺病。所有剂量的拉沙洛西处理均预防了ABPE。拉沙洛西降低了瘤胃乙酸和丁酸含量,增加了丙酸浓度(P<0.01)。(摘要截取自250词)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验